HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unilever Extends Dove Into OTC Sanitizer Space And Its Hygiene Product Sales Increase 19%

Executive Summary

Growing consumer demand for OTC hand sanitizers driven by the pandemic prompted Unilever to extend its iconic soap brand Dove into the antibacterial market with a hand sanitizer line promoted also to moisturize skin.

You may also be interested in...



P&G Health, Hygiene Brands Ride Consumer ‘Trust’ To Sales Growth Amid Pandemic Uncertainty

“There’s a heightened need for products that deliver against health, hygiene and clean home concerns and a willingness to spend just a little bit more to ensure that I’m using a product that I know and trust,” says CFO Jon Moeller 

Unilever H1 Benefits From Sanitizer Blitz; Leadership Expects Lasting Hygiene ‘Preoccupation’

Unilever’s leadership is optimistic about its enormously expanded hygiene business – both skin cleansing and home cleaning – inasmuch as it doubts that a full COVID-19 recovery is in sight. The firm launched hand sanitizers in 65 new markets in just five months, helping to offset plunging sales in other areas of its business that were heavily impacted by lockdowns around the world.

Guidance Opening Sanitizer Production Stirs Firms Including Anheuser-Busch, Dow, Kodak

Dow Chemical, Anheuser-Busch and Kodak designate manufacturing for hand sanitizers and donate products to fight COVID-19. Dow is making up to 15 tons of sanitizer a day while Kodak donates formulas to New York's “NYS Clean” sanitizer distribution program.

Topics

Related Companies

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel